Summary
The Global Probiotics Market is projected to grow significantly from USD 72,577.36 million in 2025 to USD 199,724.70 million by 2036, reflecting strong consumer demand for gut health and functional nutrition. This expansion corresponds to a robust CAGR of 9.82% during the forecast period.
Growing Awareness of Digestive Wellness
Increasing public awareness about digestive health has become a key growth factor for the Global Probiotics Market as a large number of consumers demand products that support gut balance and overall health. Government-backed education campaigns and nutrition advice have enhanced consumers' trust in probiotics as a regular part of healthy lifestyles.
Segment-Wise Snapshot of the Market
Product Type
- Probiotic Food & Beverages: Widely consumed for daily gut health support
- Probiotic Dietary Supplements: Targeted solutions for specific health concerns
- Animal Feed Probiotics: Enhances livestock digestion and overall productivity
Ingredient
- Bacteria-Based Probiotics: Dominant type with proven clinical effectiveness
- Yeast-Based Probiotics: Supports immunity and digestive balance efficiently
Application
- Human Health Wellness: Rising demand for preventive healthcare solutions
- Animal Nutrition Health: Improves animal growth and disease resistance
Distribution Channel
- Supermarkets Hypermarkets: Primary channel for mass consumer accessibility
- Health & Wellness Stores: Preferred for specialized probiotic product choices
- Online Retailers: Rapidly growing channel driven by convenience demand
- Specialty Organic Stores: Niche demand for natural probiotic offerings
Global Regional Snapshot
North America and Europe are mature, innovation-driven markets that benefit from strong regulatory frameworks, high consumer awareness, and extensive use of functional probiotic products. Asia Pacific is at the forefront of global growth due to cultural acceptance and higher income, while South America and the Middle East & Africa are emerging as regions with high potentials due to urbanization and increased health awareness.
Strategic Portfolio Realignment by Danone
In November 2025, Danone entered into an agreement to sell its Swedish probiotic fruit juice brand ProViva to Lactalis. This move is in line with Danone's strategic decision to reduce its product range. Besides the transfer of the Osterlenmejeriet manufacturing plant, the deal also reflects the company's intention to optimize its core business and allocate resources efficiently.
Targeted Consumer Segmentation Advantage
By creating demographic-specific probiotic products, manufacturers are able to address particular health needs such as providing immunity boost for kids or improving nutrient absorption in elderly.
Key Report Attributes
- Market Size 2025: USD 72,577.36 Million
- Market Size 2036: USD 1,99,724.70 Million
- CAGR (2025-2036): 9.82%
- Base Year: 2024
- Market Forecast Period: 2025-2036
Industry Segmentations Growth
- By Product Type: Probiotic Food & Beverages - 9.45%, Probiotic Dietary Supplements - 12.12%.
- By Ingredient Type: Bacteria-Based Probiotics - 9.43%, Yeast-Based Probiotics - 10.43%.
- By Application: Human Health Wellness - 9.97%, Animal Nutrition Health - 8.32%.
- By Distribution Channel: Supermarkets and Hypermarkets - 9.99%, Health & Wellness Stores - 7.92%.
ページTOPに戻る
Table of Contents
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY ..... 28
2 MARKET INTRODUCTION .......... 30
2.1 DEFINITION ........ 30
2.2 SCOPE OF THE STUDY ......... 30
2.3 RESEARCH OBJECTIVE ....... 30
2.4 MARKET STRUCTURE ......... 31
3 RESEARCH METHODOLOGY ........... 32
3.1 OVERVIEW .......... 32
3.2 DATA FLOW ........ 34
3.2.1 DATA MINING PROCESS .......... 34
3.3 PURCHASED DATABASE: ........... 35
3.4 SECONDARY SOURCES: ....... 36
3.4.1 SECONDARY RESEARCH DATA FLOW: ........... 37
3.5 PRIMARY RESEARCH: .......... 38
3.5.1 PRIMARY RESEARCH DATA FLOW: ........ 39
3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED .......... 40
3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE ....... 40
3.6 APPROACHES FOR MARKET SIZE ESTIMATION: ....... 41
3.6.1 REVENUE ANALYSIS APPROACH ..... 41
3.7 DATA FORECASTING..... 42
3.7.1 DATA FORECASTING TYPE ....... 42
3.8 DATA MODELING ..... 43
3.8.1 MICROECONOMIC FACTOR ANALYSIS: .......... 43
3.8.2 DATA MODELING: ...... 44
3.9 TEAMS AND ANALYST CONTRIBUTION ......... 46
4 MARKET DYNAMICS ........... 48
4.1 INTRODUCTION ........ 48
4.2 MARKET TRENDS AND GROWTH AFFECTING FACTORS ..... 48
4.3 DRIVERS ........ 49
4.3.1 INCREASING HEALTH AWARENESS ........ 49
4.3.2 GROWING DEMAND FOR FUNCTIONAL FOODS ...... 50
4.3.3 RISING CONSUMER BASE SEEKING DIGESTIVE HEALTH SOLUTIONS ......... 50
4.3.4 EXPANSION OF E-COMMERCE PLATFORMS .......... 51
4.3.5 REGULATORY SUPPORT AND RESEARCH ADVANCEMENTS ........ 51
4.4 RESTRAINTS ...... 52
4.4.1 HIGH COST OF PRODUCTION .......... 52
4.4.2 STRINGENT REGULATORY FRAMEWORK ........ 53
4.4.3 CONSUMER SKEPTICISM ABOUT HEALTH CLAIMS ....... 53
4.4.4 LACK OF STANDARDIZATION IN PROBIOTIC PRODUCTS...... 53
4.4.5 LIMITED CONSUMER KNOWLEDGE ON PRODUCT BENEFITS ....... 54
4.5 OPPORTUNITIES ...... 55
4.5.1 INCREASING CONSUMER AWARENESS OF PROBIOTICS ...... 55
4.5.2 INNOVATION IN PRODUCT FORMULATIONS AND DELIVERY FORMATS ..... 55
4.5.3 EXPANSION INTO EMERGING MARKETS ........ 55
4.5.4 TARGETED MARKETING STRATEGIES FOR SPECIFIC DEMOGRAPHICS ...... 56
4.5.5 COLLABORATIONS WITH HEALTH PROFESSIONALS AND FITNESS INFLUENCERS .......... 56
5 MARKET FACTOR ANALYSIS ........... 58
5.1 VALUE CHAIN ANALYSIS ......... 58
5.1.1 UPSTREAM R&D, STRAIN OWNERSHIP & INTELLECTUAL PROPERTY CREATION ...... 58
5.1.2 INPUT OPTIMIZATION, MEDIA DESIGN & COST STRUCTURE ENGINEERING ...... 58
5.1.3 BIOPROCESS MANUFACTURING, SCALE-UP & YIELD CONVERSION ........... 58
5.1.4 FORMULATION ENGINEERING, STABILITY ENHANCEMENT & SHELF-LIFE VALUE PROTECTION ..... 58
5.1.5 MARKET ACCESS, CHANNEL EXECUTION & BRAND-LED MONETIZATION ......... 59
5.2 SUPPLY CHAIN ANALYSIS ....... 60
5.2.1 STRAIN SOURCING & CULTURE DEVELOPMENT ........... 60
5.2.2 RAW MATERIAL & INPUT SUPPLY ........... 60
5.2.3 MANUFACTURING AND PROCESSING ..... 60
5.2.4 FORMULATION, PACKAGING & STORAGE ....... 60
5.2.5 DISTRIBUTION & END USE CHANNEL ...... 61
5.3 PORTER'S FIVE FORCES MODEL ........... 62
5.3.1 THREAT OF NEW ENTRANTS ........... 62
5.3.2 BARGAINING POWER OF SUPPLIERS ...... 63
5.3.3 THREAT OF SUBSTITUTES ....... 63
5.3.4 BARGAINING POWER OF BUYERS (PATIENTS) ....... 63
5.3.5 INTENSITY OF RIVALRY ........... 63
5.4 REGULATORY UPDATE ....... 64
5.5 CONSUMER BEHAVIOUR ANALYSIS .......... 65
5.6 STRATEGIC INSIGHTS ......... 67
6 GLOBAL PROBIOTICS MARKET, BY PRODUCT TYPE ....... 70
6.1 INTRODUCTION ........ 70
7 GLOBAL PROBIOTICS MARKET, BY INGREDIENT TYPE ......... 74
7.1 INTRODUCTION ........ 74
8 GLOBAL PROBIOTICS MARKET, BY APPLICATION ........... 78
8.1 INTRODUCTION ........ 78
9 GLOBAL PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL ..... 82
9.1 INTRODUCTION ........ 82
10 GLOBAL PROBIOTICS MARKET, BY REGION ...... 85
10.1 OVERVIEW .......... 85
10.2 NORTH AMERICA ........... 87
10.2.1 US........ 96
10.2.2 CANADA ..... 102
10.3 EUROPE ......... 109
10.3.1 GERMANY .......... 119
10.3.2 FRANCE ...... 126
10.3.3 UK ....... 132
10.3.4 ITALY .......... 139
10.3.5 SPAIN ......... 146
10.3.6 REST OF EUROPE ....... 153
10.4 ASIA PACIFIC ..... 160
10.4.1 CHINA ......... 170
10.4.2 INDIA .......... 176
10.4.3 JAPAN ........ 182
10.4.4 SOUTH KOREA ........... 189
10.4.5 MALAYSIA ......... 196
10.4.6 THAILAND .......... 203
10.4.7 INDONESIA ......... 210
10.4.8 REST OF ASIA-PACIFIC ..... 217
10.5 SOUTH AMERICA ........... 224
10.5.1 BRAZIL ........ 234
10.5.2 MEXICO ...... 240
10.5.3 ARGENTINA ....... 247
10.5.4 REST OF SOUTH AMERICA ....... 253
10.6 MIDDLE EAST AND AFRICA ...... 260
10.6.1 GCC COUNTRIES........ 269
10.6.2 SOUTH AFRICA .......... 275
10.6.3 REST OF MIDDLE EAST & AFRICA ........... 282
11 COMPETITIVE LANDSCAPE ...... 290
11.1 INTRODUCTION ........ 290
11.2 MARKET SHARE ANALYSIS, 2025 ....... 290
11.3 COMPETITOR DASHBOARD....... 291
11.4 PUBLIC PLAYERS STOCK SUMMARY ........ 292
11.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL ........ 292
11.1 KEY DEVELOPMENTS & GROWTH STRATEGIES ........ 293
11.1.1 PRODUCT LAUNCH ........... 293
11.1.2 ACQUISITION ..... 295
12 COMPANY PROFILES ......... 297
12.1 DANONE SA ........ 297
12.1.1 COMPANY OVERVIEW ....... 297
12.1.2 FINANCIAL OVERVIEW ...... 298
12.1.3 PRODUCTS OFFERED ........ 298
12.1.4 KEY DEVELOPMENTS ........ 299
12.1.5 SWOT ANALYSIS ....... 300
12.1.6 KEY STRATEGIES ....... 300
12.2 NESTLÉ S.A. ........ 301
12.2.4 KEY DEVELOPMENTS ........ 303
12.2.5 SWOT ANALYSIS ....... 304
12.3 YAKULT HONSHA .......... 305
12.3.1 COMPANY OVERVIEW ....... 305
12.3.2 FINANCIAL OVERVIEW ...... 305
12.3.3 PRODUCTS OFFERED ........ 306
12.3.5 SWOT ANALYSIS ....... 307
12.3.6 KEY STRATEGIES ....... 307
12.4 ARLA FOODS INGREDIENT ........ 308
12.4.1 COMPANY OVERVIE .......... 308
12.4.2 FINANCIAL OVERVIEW ...... 309
12.4.3 PRODUCTS OFFERED ........ 309
12.4.4 KEY DEVELOPMENTS ........ 310
12.4.5 SWOT ANALYSIS ....... 311
12.4.6 KEY STRATEGIES ....... 312
12.5 NEXTFOODS, INC. ........... 313
12.5.1 COMPANY OVERVIEW ....... 313
12.5.2 FINANCIAL OVERVIEW ...... 313
12.5.3 PRODUCTS OFFERED ........ 314
12.5.5 SWOT ANALYSIS ....... 315
12.5.6 KEY STRATEGY .......... 315
12.6 PROBI AB ...... 316
12.6.1 COMPANY OVERVIEW ....... 316
12.6.2 FINANCIAL OVERVIEW ...... 317
12.6.3 PRODUCTS OFFERED ........ 317
12.6.4 KEY DEVELOPMENTS ........ 318
12.6.5 SWOT ANALYSIS ....... 319
12.6.6 KEY STRATEGIES ....... 319
12.7 MORINAGA MILK INDUSTRY CO., LTD. ..... 320
12.7.1 COMPANY OVERVIEW ....... 320
12.7.2 FINANCIAL OVERVIEW ...... 321
12.7.3 PRODUCTS/SERVICES OFFERED ...... 321
12.7.4 KEY DEVELOPMENTS ........ 322
12.7.5 SWOT ANALYSIS ....... 323
12.8 KERRY GROUP .......... 324
12.8.1 COMPANY OVERVIEW ....... 324
12.8.2 FINANCIAL OVERVIEW ...... 325
12.8.3 PRODUCTS OFFERED ........ 326
12.8.5 SWOT ANALYSIS ....... 327
12.8.6 KEY STRATEGIES ....... 327
12.9 LALLEMAND INC ..... 328
12.9.1 COMPANY OVERVIE .......... 328
12.9.2 FINANCIAL OVERVIEW ...... 329
12.9.3 PRODUCTS OFFERED ........ 329
12.9.4 KEY DEVELOPMENTS ........ 330
12.9.5 SWOT ANALYSIS ....... 331
12.9.6 KEY STRATEGIES ....... 331
12.10 BIOGAIA AB ......... 332
12.10.1 COMPANY OVERVIEW ....... 332
12.10.2 FINANCIAL OVERVIEW ...... 333
12.10.3 PRODUCTS OFFERED ........ 334
12.10.5 SWOT ANALYSIS ....... 335
12.10.6 KEY STRATEGY .......... 336
13 DATA CITATIONS ......... 337